@windhamvp

Personal Genome Diagnostics Launches RNAcompleteTM Allowing Co-Extraction and Analysis of RNA and DNA from a Single FFPE Tissue Sample

–Researchers Can Combine Results from RNAcomplete with PGDx’s CancerXOMETM Whole Exome Sequencing to Obtain Powerful Information on Gene Expression and Mutational Status from a Single Sample– BALTIMORE, MD – Personal … Continued

Personal Genome Diagnostics Selected to Participate in U.S. Cancer Moonshot Effort to Jump Start Liquid Biopsy Database

PGDx Joins Consortium of Public, Private and Academic Innovators Developing Pilot for a Blood Profiling Atlas to Help Ensure the Validity, Utility and Accessibility of Liquid Biopsies for Cancer Research, … Continued

Personal Genome Diagnostics Launches PlasmaSELECT 64 Panel for Non-Invasive Pan-Cancer Tumor Profiling

—Accurately Identifies Clinically Actionable Genetic Alterations across Multiple Cancer Types from Blood or Plasma without the Need for Invasive Biopsies— BALTIMORE, MD,  – Personal Genome Diagnostics Inc. (PGDx), a leading … Continued

NeoTract, Inc. Announces Positive Coverage Decisions from Geisinger Health Plan and Emblem Health for UroLift® Implant Procedure

NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced new positive coverage decisions from Geisinger Health Plan and Emblem Health, expanding … Continued